Richard C. Rosenzweig, Senior Vice President of Corporate Development, General Counsel, and Secretary, has demonstrated a consistent pattern of insider trading activity focused exclusively on shares of DENTSPLY SIRONA Inc. (XRAY) over the past two years. His transactions, totaling 24 filings, reveal a notable divergence between buying and selling activity. Rosenzweig has executed purchases amounting to $148,340.60, primarily concentrated in early 2024 and early 2025. For instance, on March 18, 2024, he acquired shares valued at $69,315.87, followed by another significant purchase on March 26, 2025, worth $74,534.90. These acquisitions suggest a strategic accumulation of XRAY stock during specific periods.
In contrast, Rosenzweig’s selling activity has been more substantial, totaling $327,594.36, with the majority occurring in March 2024 and March 2025. Notably, on March 1, 2024, he sold shares valued at $157,566.72 and $45,114.12 in separate transactions. Similarly, on March 3, 2025, he executed sales worth $79,246.44 and $23,217.48. These disposals indicate a deliberate reduction in his holdings, particularly during the first quarters of both years. While Rosenzweig’s recent trades show no activity, his historical pattern reflects a clear bias toward selling, with occasional significant purchases. This activity underscores a measured approach to managing his XRAY holdings, aligning with his role as a corporate insider.
AI-assisted summary